456 hedge funds and large institutions have $10.6B invested in DexCom in 2019 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 146 increasing their positions, 169 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

3.04% less ownership

Funds ownership: 397.57%394.52% (-3%)

14% less repeat investments, than reductions

Existing positions increased: 146 | Existing positions reduced: 169

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

Holders
456
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$92.9M
Puts
$62.7M
Net Calls
Net Calls Change

Top Sellers

1 -$188M
2 -$88M
3 -$79M
4
Two Sigma Investments
Two Sigma Investments
New York
-$74.3M
5
Morgan Stanley
Morgan Stanley
New York
-$54.1M
Name Holding Trade Value Shares
Change
Change in
Stake
326
$321K
327
$319K
328
$315K
329
$314K
330
$312K
331
$304K
332
$304K
333
$301K
334
$287K
335
$274K
336
$274K
337
$271K
338
$267K
339
$263K
340
$263K
341
$260K
342
$252K
343
$247K
344
$245K
345
$244K
346
$243K
347
$238K
348
$238K
349
$238K
350
$230K